Regeneron and Sanofi cut US list price of Praluent
Regeneron and Sanofi have announced they have lowered the list price of high...
Focus:
-
![J&J to disclose medicine prices in television ads]()
Johnson & Johnson to disclose drug prices in television ads
-
![US drug prices second hearing]()
US Senate invites seven pharma majors to testify on price hikes
-
![FDA funding post-shutdown]()
FDA returns to work post-shutdown, but February funding lapse looms
-
![causes of trial termination]()
Are academic-run clinical trials more likely to be terminated?
-
![US drug rebates]()
US Government’s new rule targets drug industry’s rebate system
-
![anti-ageing start-ups]()
Venture financing deals on the rise in the longevity space
Most Read
- Regeneron and Sanofi cut US list price of Praluent
- Johnson & Johnson to disclose drug prices in television ads
- US Senate invites seven pharma majors to testify on price hikes
- FDA returns to work post-shutdown, but February funding lapse looms
- Are academic-run clinical trials more likely to be terminated?
Company A-Z
Latest Content
Medicines Manufacturing Innovation Centre, Renfrewshire
The Centre for Process Innovation (CPI), the University of Strathclyde, Scottish Enterprise, Innovate UK, AstraZeneca and GlaxoSmithKline (GSK) have partnered to open the Medicines Manufacturing Innovation Centre (MMIC) in Renfrewshire, Scotland.
Glenmark Pharmaceuticals to establish new company in US
India-based Glenmark Pharmaceuticals is set to spin-off its innovation business into a new company in the US to increase focus on innovation and advance its pipeline towards commercialisation.
Meet FPS at Events Throughout 2019
FPS has announced its presence at the following events for 2019.
Meissner Filtration Products’ Manufacturing Facility, Castlebar, Ireland
Meissner Filtration Products is developing a new manufacturing facility in County Mayo, Castlebar, Ireland.
Polpharma Finished Dosage Formulation Dossier – Under Development
This white paper outlines Polpharma B2B's finished dosage formulations (FDF) that are currently under development.
Novartis to divest Proleukin’s US rights to Clinigen for $210m
Novartis has signed an agreement to divest the US rights to its Proleukin (aldesleukin) medicine to UK-based Clinigen Group for a total cash consideration of up to $210m.
Regeneron and Sanofi cut US list price of Praluent
Regeneron and Sanofi have announced they have lowered the list price of high cholesterol drug Praluent (alirocumab) in the US by approximately 60%.
Pfizer recalls valsartan-containing blood pressure drug in Japan
Pfizer's subsidiary in Japan has announced a recall of blood pressure drug Amvalo that was found to contain impurities in its active ingredient valsartan, which is indicated to treat high blood pressure.
Johnson & Johnson to disclose drug prices in television ads
Johnson & Johnson has announced plans to disclose the price of its prescription medicines directly to customers on TV advertisements in a bid to drive transparency.
ETO Sterilisers Brochure
RSD designs and manufactures ethylene oxide (EO) sterilisers for the sterilisation of thermosensitive products (those that are sensitive to heat and humidity) such as syringes, catheters, dialysis cartridges, plastic dressings and sutures.
Latest News
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Go Top
